We report the identification of mutations in the p53 effector CDKN1A (p21WAF1/CIP1) and the protocadherin FAT1, describe the genomic landscape of the set of cancers, and detect associations between tumour stage and measures of mutation burden. This evidence concerns the gene CDKN1A and neoplasm.